- $543.46m
- $504.43m
- $111.06m
- 86
- 29
- 57
- 58
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 18.01 | ||
| PEG Ratio (f) | 2.8 | ||
| EPS Growth (f) | 6.87% | ||
| Dividend Yield (f) | 4.89% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 15.22 | ||
| Price to Tang. Book | 21.82 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.89 | ||
| EV to EBITDA | 14.46 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 68.53% | ||
| Return on Equity | 80.54% | ||
| Operating Margin | 29% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 71.23 | 102.93 | 105.15 | 109.89 | 111.06 | 112.5 | 116.2 | 12.06% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +23.06 | +64.22 | +0.46 | -10.05 | -0.9 | +6.68 | +7.3 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
OTC Markets Group Inc. operates regulated markets for trading 12,000 United States and international securities. It has three public markets: OTCQX Best Market, OTCQB Venture Market and Pink Open Market. It operates three business lines: OTC Link, Market Data Licensing, and Corporate Services. Its wholly owned subsidiary, OTC Link LLC, a FINRA member broker-dealer, operates OTC Link ATS, OTC Link ECN, and OTC Link NQB, each an SEC-regulated Alternative Trading Systems (ATSs). OTC Link ATSs provide critical market infrastructure that broker-dealers rely on to facilitate trading. Its model offers companies more efficient access to the United States financial markets. Its Market Data Licensing business provides its subscribers with access to extensive market data and financial information, including real-time, delayed, and end-of-day quotation and trading data, as well as a security master with issuer-level data. It also offers a number of data products and tools for compliance teams.
Directors
- Neal Wolkoff CHM (63)
- R. Cromwell Coulson CEO (53)
- Antonia Georgieva CFO
- Beatrice Ordonez CFO (48)
- Michael Modeski CEX (48)
- Matthew Fuchs EVP (45)
- Lisabeth Heese EVP (51)
- Jason Paltrowitz EVP (47)
- Bruce Ostrover CTO (57)
- Kristie Harkins CMO
- Daniel Zinn GCN (42)
- Gary Baddeley DRC (54)
- Louisa Schneider DRC (43)
- Andrew Wimpfheimer DRC (63)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 14th, 1997
- Public Since
- September 16th, 2009
- No. of Employees
- 82
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
Pink Sheets on Nasdaq- Shares in Issue
- 11,979,165
- Address
- 300 Vesey Street, 12th Floor, NEW YORK, 10282
- Web
- https://www.otcmarkets.com/
- Phone
- +1 2128964400
- Auditors
- Deloitte & Touche LLP
Latest News for OTCM
Upcoming Events for OTCM
OTC Markets OTCQX Best 50 Investor Conference (Virtual)
OTC Markets Metals and Mining Investor Conference (Virtual)
Q1 2025 OTC Markets Group Inc Earnings Release
Q2 2025 OTC Markets Group Inc Earnings Release
Similar to OTCM
141 Capital
Pink Sheets on Nasdaq
Abaxx Technologies
Pink Sheets on Nasdaq
Alchemy Creative
Pink Sheets on Nasdaq
Alliance Creative
Pink Sheets on Nasdaq
Amaya Global Holdings
Pink Sheets on Nasdaq
FAQ
As of Today at 22:29 UTC, shares in OTC Markets are trading at $45.37. This share price information is delayed by 15 minutes.
Shares in OTC Markets last closed at $45.37 and the price had moved by -11.19% over the past 365 days. In terms of relative price strength the OTC Markets share price has underperformed the S&P500 Index by -16.08% over the past year.
There is no consensus recommendation for this security.
Find out moreThe OTC Markets dividend yield is 1.19% based on the trailing twelve month period.
Last year, OTC Markets paid a total dividend of $0.54, and it currently has a trailing dividend yield of 1.19%. We do not have any data on when OTC Markets is to next pay dividends.
We do not have data on when OTC Markets is to next pay dividends. The historic dividend yield on OTC Markets shares is currently 1.19%.
To buy shares in OTC Markets you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $45.37, shares in OTC Markets had a market capitalisation of $543.46m.
Here are the trading details for OTC Markets:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: OTCM
Based on an overall assessment of its quality, value and momentum OTC Markets is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in OTC Markets is $63.00. That is 38.87% above the last closing price of $45.37.
Analysts covering OTC Markets currently have a consensus Earnings Per Share (EPS) forecast of $2.47 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like OTC Markets. Over the past six months, its share price has outperformed the S&P500 Index by +1.85%.
As of the last closing price of $45.37, shares in OTC Markets were trading -7.56% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The OTC Markets PE ratio based on its reported earnings over the past 12 months is 18.01. The shares last closed at $45.37.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
OTC Markets' management team is headed by:
- Neal Wolkoff - CHM
- R. Cromwell Coulson - CEO
- Antonia Georgieva - CFO
- Beatrice Ordonez - CFO
- Michael Modeski - CEX
- Matthew Fuchs - EVP
- Lisabeth Heese - EVP
- Jason Paltrowitz - EVP
- Bruce Ostrover - CTO
- Kristie Harkins - CMO
- Daniel Zinn - GCN
- Gary Baddeley - DRC
- Louisa Schneider - DRC
- Andrew Wimpfheimer - DRC